We considered 159 BC patients with available primary tumor samples and data on AR and ER expression, of whom 125 patients had luminal tumor (defined as ER ≥1% and/or PgR ≥1% with any Ki67 or HER2 values). The gene discussed is ERBB2; the disease is breast cancer.